Stay updated on Study of ARO-HSD in NASH Clinical Trial
Sign up to get notified when there's something new on the Study of ARO-HSD in NASH Clinical Trial page.

Latest updates to the Study of ARO-HSD in NASH Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record describes a completed Phase 1/2a study evaluating ARO-HSD in healthy volunteers and people with suspected NASH, including its design, eligibility criteria, outcomes, and Auckland study location. It also provides study results-related dates, a publication, and protocol and statistical analysis plan documents.SummaryDifference57%

- Check21 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedA notice appears above the ClinicalTrials.gov header announcing NIH transition updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check35 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe ClinicalTrials.gov release label changes from v3.7.0 to v3.7.1. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check63 days agoChange DetectedAccess to the study record now returns a 403 Forbidden page, replacing the expected study details with a site error message. This indicates an access issue rather than a substantive update to the study information.SummaryDifference20%

Stay in the know with updates to Study of ARO-HSD in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ARO-HSD in NASH Clinical Trial page.